Approval for the barricaid anular closure device (acd). The device is indicated for reducing the incidence of reherniation, and reoperation in skeletally mature patients with radiculopathy (with or without back pain) attributed to a posterior or posterolateral herniation, and confirmed by history, physical examination and imaging studies which demonstrate neural compression using mri to treat a large anular defect (between 4-6 mm tall and between 6-10 mm wide) following a primary discectomy procedure (excision of herniated intervertebral disc) at a single level between l4 and s1.
Supplemental Filings
Supplement Number | Date | Supplement Type |
P160050 | | Original Filing |
S006 |
2020-04-22 |
Normal 180 Day Track No User Fee |
S005 |
2020-04-16 |
Normal 180 Day Track No User Fee |
S004 | | |
S003 |
2019-03-19 |
Real-time Process |
S002 |
2019-03-11 |
135 Review Track For 30-day Notice |
S001 |
2019-03-08 |
Normal 180 Day Track No User Fee |
NIH GUDID Devices